首页 > 最新文献

Journal of coronary artery disease最新文献

英文 中文
Bilateral Internal Thoracic Artery Graft in Coronary Artery Bypass Grafting 双侧胸内动脉在冠状动脉搭桥术中的应用
Pub Date : 2019-01-01 DOI: 10.7793/JCAD.25.005
T. Fukui
Percutaneous coronary intervention (PCI) is the first choice for treating simple coronary artery lesions because of the progress of coronary stent techniques in recent years. However, cases involving multivessel coronary artery disease are generally treated with coronary artery bypass grafting (CABG). Several recent studies have demonstrated that the long-term outcomes of CABG are superior to those of PCI in patients with multivessel and/or left main disease 1 -. In Japanese guidelines on revascularization for stable coronary artery disease, which were revised in 2018, CABG is considered a class I recommendation for all types of stenosis location except for “one vessel disease without proximal LAD stenosis” . CABG remains the superior method for treating selected patient groups. Saphenous vein graft (SVG) is the most popular graft used in CABG. A survey of the Japanese Association for Coronary Artery Surgery demonstrated that SVG is used more than 40% inpatients undergoing CABG . However, SVG shows poor patency rates and does not improve long-term morbidity . Conversely, the left internal thoracic artery (ITA) has superior graft patency and excellent clinical results . Several trials reported a 10-year patency of the left ITA of 90%–95% compared with 50% in SVG 13, . The use of arterial conduits in CABG has been hypothesized to improve long-term results . Therefore, some arterial grafts have been used as bypass grafts including the right ITA , radial artery 17) and right gastroepiploic artery . Various combinations of these arterial grafts have been employed (Fig. 1) and many retrospective studies have supported their safety and effectiveness. These findings suggest that arterial grafts are better suited for coronary bypass grafts than venous grafts. Among the arterial grafts used for CABG, ITA has the greatest long-term patency rate. Many factors regarding resistance to the development of atherosclerosis in ITA have been indicated by numerous studies: structurally, its endothelial layer shows fewer fenestrations, lower intercellular junction permeability, greater antithrombotic molecules such as heparin sulfate and tissue plasminogen activator and higher endothelial nitric oxide production. These are some of the unique ways that make the ITA impervious to the transfer of lipoproteins, which are responsible for atherosclerosis development 19 -. In comparison, the radial artery has a relatively thick media and a tendency for distal intimal hyperplasia . Therefore, the use of bilateral ITA graft is theoretically reasonable for CABG in terms of long-term patency and survival. Numerous observational studies and metaanalyses have demonstrated the superiority of bilateral ITA in terms of survival compared with single ITA. Current guidelines therefore recommend bilateral ITA for CABG as class IIa 9, . In this review, the advantages and disadvantages of using bilateral ITA in CABG are discussed. Moreover, the only randomized trial comparing bilateral and
近年来,由于冠状动脉支架技术的进步,经皮冠状动脉介入治疗(PCI)已成为治疗单纯性冠状动脉病变的首选方法。然而,涉及多支冠状动脉疾病的病例通常采用冠状动脉旁路移植术(CABG)治疗。最近的几项研究表明,对于多血管和/或左主干疾病患者,CABG的长期预后优于PCI 1 -。在2018年修订的日本稳定型冠状动脉疾病血运重建术指南中,除了“无近端LAD狭窄的一种血管疾病”外,CABG被认为是所有类型狭窄位置的I级推荐。CABG仍然是治疗特定患者组的首选方法。隐静脉移植物(SVG)是冠状动脉搭桥术中最常用的移植物。日本冠状动脉外科协会的一项调查表明,超过40%的CABG住院患者使用SVG。然而,SVG显示出较差的通畅率,并不能改善长期发病率。相反,左胸内动脉(ITA)具有良好的移植物通畅性和良好的临床效果。几项试验报告10年左ITA的通畅率为90%-95%,而SVG的通畅率为50%。在冠脉搭桥中使用动脉导管被认为可以改善长期效果。因此,一些动脉移植物被用作旁路移植物,包括右ITA、桡动脉和右胃网膜动脉。这些动脉移植的各种组合已被采用(图1),许多回顾性研究支持其安全性和有效性。这些发现表明动脉移植比静脉移植更适合冠状动脉旁路移植。在冠脉搭桥所用的动脉移植物中,ITA长期通畅率最高。许多研究表明,ITA抵抗动脉粥样硬化发展的许多因素:在结构上,其内皮层开窗较少,细胞间连接处通透性较低,抗血栓分子如硫酸肝素和组织纤溶酶原激活剂较多,内皮细胞一氧化氮产量较高。这些是一些独特的方式,使ITA不受脂蛋白转移的影响,而脂蛋白是动脉粥样硬化发展的原因。相比之下,桡动脉具有相对较厚的中膜和远端内膜增生的倾向。因此,从长期通畅和生存的角度来看,双侧ITA移植在CABG中理论上是合理的。许多观察性研究和荟萃分析表明,双侧ITA与单侧ITA相比,在生存方面具有优势。因此,目前的指南建议将CABG的双边ITA列为IIa级。本文就双侧ITA在CABG中的优缺点进行了讨论。此外,我们还回顾了迄今为止比较双侧和单侧ITA的唯一随机试验。
{"title":"Bilateral Internal Thoracic Artery Graft in Coronary Artery Bypass Grafting","authors":"T. Fukui","doi":"10.7793/JCAD.25.005","DOIUrl":"https://doi.org/10.7793/JCAD.25.005","url":null,"abstract":"Percutaneous coronary intervention (PCI) is the first choice for treating simple coronary artery lesions because of the progress of coronary stent techniques in recent years. However, cases involving multivessel coronary artery disease are generally treated with coronary artery bypass grafting (CABG). Several recent studies have demonstrated that the long-term outcomes of CABG are superior to those of PCI in patients with multivessel and/or left main disease 1 -. In Japanese guidelines on revascularization for stable coronary artery disease, which were revised in 2018, CABG is considered a class I recommendation for all types of stenosis location except for “one vessel disease without proximal LAD stenosis” . CABG remains the superior method for treating selected patient groups. Saphenous vein graft (SVG) is the most popular graft used in CABG. A survey of the Japanese Association for Coronary Artery Surgery demonstrated that SVG is used more than 40% inpatients undergoing CABG . However, SVG shows poor patency rates and does not improve long-term morbidity . Conversely, the left internal thoracic artery (ITA) has superior graft patency and excellent clinical results . Several trials reported a 10-year patency of the left ITA of 90%–95% compared with 50% in SVG 13, . The use of arterial conduits in CABG has been hypothesized to improve long-term results . Therefore, some arterial grafts have been used as bypass grafts including the right ITA , radial artery 17) and right gastroepiploic artery . Various combinations of these arterial grafts have been employed (Fig. 1) and many retrospective studies have supported their safety and effectiveness. These findings suggest that arterial grafts are better suited for coronary bypass grafts than venous grafts. Among the arterial grafts used for CABG, ITA has the greatest long-term patency rate. Many factors regarding resistance to the development of atherosclerosis in ITA have been indicated by numerous studies: structurally, its endothelial layer shows fewer fenestrations, lower intercellular junction permeability, greater antithrombotic molecules such as heparin sulfate and tissue plasminogen activator and higher endothelial nitric oxide production. These are some of the unique ways that make the ITA impervious to the transfer of lipoproteins, which are responsible for atherosclerosis development 19 -. In comparison, the radial artery has a relatively thick media and a tendency for distal intimal hyperplasia . Therefore, the use of bilateral ITA graft is theoretically reasonable for CABG in terms of long-term patency and survival. Numerous observational studies and metaanalyses have demonstrated the superiority of bilateral ITA in terms of survival compared with single ITA. Current guidelines therefore recommend bilateral ITA for CABG as class IIa 9, . In this review, the advantages and disadvantages of using bilateral ITA in CABG are discussed. Moreover, the only randomized trial comparing bilateral and","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71173911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
“Sandwich Technique” via a Right Ventricular Incision for Ultra-acute Repair of Post-infarction Ventricular Septal Defects “三明治技术”经右心室切口超急性修复梗死后室间隔缺损
Pub Date : 2019-01-01 DOI: 10.7793/JCAD.25.19-00001
S. Isoda, R. Izubuchi, I. Yamazaki, K. Uchida, Shotaro Kaneko, M. Goda, Yoshimi Yano, M. Masuda
Post-infarction ventricular septal defect (VSD) is a life-threatening complication of transmural acute myocardial infarction (AMI), with a poor survival rate despite medical therapy 1, . Untreated patients had a 24% mortality rate in a day and 80% within the first month 3, . Although surgical repair seems to provide better result than medical therapy, surgical results in 2014 in Japan showed 28.6% 30-day mortality rate and 33.5% in-hospital mortality rate 5, . The Society of Thoracic Surgeons database showed operative mortality rate of 54.1% when repair was attempted within 7 days after AMI . Although untreated post-infarction VSD in the ultra-acute phase has an extremely high mortality rate, surgeons are reluctant to perform emergent surgery due to fragility of the infarcted myocardium. Problems with the previous surgical techniques include residual leak, uncontrolled bleeding, and technical difficulty 2, -. To resolve these problems, we have developed a sandwich technique via a right ventricular (RV) approach -. This technique involves the placement of patches on both the left and right sides of the septum, pinching the VSD sealed with surgical adhesive between the two patches via an RV approach (Fig. 1a). Since patients with post-infarction VSD tend to fall in severe lung edema or cardiac tamponade quickly and the condition sometimes become irreversible, necessitating postoperative cardiopulmonary support, we used our technique in the ultra-acute phase, with the Original Article
梗死后室间隔缺损(VSD)是跨壁急性心肌梗死(AMI)的一种危及生命的并发症,尽管药物治疗,但生存率很低。未经治疗的患者一天死亡率为24%,第一个月内死亡率为80%。虽然手术修复似乎比内科治疗提供更好的效果,但2014年日本手术结果显示,30天死亡率为28.6%,住院死亡率为33.5% 5,。胸外科学会数据库显示,AMI术后7天内尝试修复的手术死亡率为54.1%。尽管在超急性期未经治疗的梗死后室间隔缺损死亡率极高,但由于梗死心肌的脆弱性,外科医生不愿进行紧急手术。以前的手术技术存在的问题包括残留渗漏、无法控制的出血和技术难度2、-。为了解决这些问题,我们开发了一种通过右心室(RV)入路的夹层技术。该技术包括在鼻中隔的左右两侧放置贴片,通过RV入路夹住两个贴片之间用外科粘合剂密封的VSD(图1a)。由于梗死后VSD患者往往会迅速出现严重的肺水肿或心包填塞,有时病情变得不可逆转,需要术后心肺支持,因此我们在超急性期使用了我们的技术,并发表了原始文章
{"title":"“Sandwich Technique” via a Right Ventricular Incision for Ultra-acute Repair of Post-infarction Ventricular Septal Defects","authors":"S. Isoda, R. Izubuchi, I. Yamazaki, K. Uchida, Shotaro Kaneko, M. Goda, Yoshimi Yano, M. Masuda","doi":"10.7793/JCAD.25.19-00001","DOIUrl":"https://doi.org/10.7793/JCAD.25.19-00001","url":null,"abstract":"Post-infarction ventricular septal defect (VSD) is a life-threatening complication of transmural acute myocardial infarction (AMI), with a poor survival rate despite medical therapy 1, . Untreated patients had a 24% mortality rate in a day and 80% within the first month 3, . Although surgical repair seems to provide better result than medical therapy, surgical results in 2014 in Japan showed 28.6% 30-day mortality rate and 33.5% in-hospital mortality rate 5, . The Society of Thoracic Surgeons database showed operative mortality rate of 54.1% when repair was attempted within 7 days after AMI . Although untreated post-infarction VSD in the ultra-acute phase has an extremely high mortality rate, surgeons are reluctant to perform emergent surgery due to fragility of the infarcted myocardium. Problems with the previous surgical techniques include residual leak, uncontrolled bleeding, and technical difficulty 2, -. To resolve these problems, we have developed a sandwich technique via a right ventricular (RV) approach -. This technique involves the placement of patches on both the left and right sides of the septum, pinching the VSD sealed with surgical adhesive between the two patches via an RV approach (Fig. 1a). Since patients with post-infarction VSD tend to fall in severe lung edema or cardiac tamponade quickly and the condition sometimes become irreversible, necessitating postoperative cardiopulmonary support, we used our technique in the ultra-acute phase, with the Original Article","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7793/JCAD.25.19-00001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71173987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Encouragement of Super-aggressive LDL-lowering Therapies 鼓励超积极的低密度脂蛋白降低疗法
Pub Date : 2019-01-01 DOI: 10.7793/jcad.25.19-00005
H. Tada, K. Sakata, M. Takamura, M. Kawashiri
Clinical usefulness of aggressive LDL-lowering therapies using statin, ezetimibe, and proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors have been shown in primary as well as in secondary prevention settings. In addition, the idea that the lower, the better story in LDL appears to be true as low as ~30 mg/dl based on recent randomized controlled trials (RCT). Moreover, aggressive LDL-lowering therapies, for either of primary prevention setting, or secondary prevention setting has been shown to be quite effective in Japanese population as well. According to those facts, recent guidelines in Europe, and in Japan suggest to lower LDL cholesterol (LDL-C) level < 70 mg/dl for high-risk patients. However, the attainment rates of such “strict” goals seem to be quite low, probably because most cardiologists still have a feeling of anxiety of extremely low LDL-C level. In this review article, we provide the idea that LDL-C is one of the well-established causal factors for atherosclerotic cardiovascular disease (ASCVD) based on the findings from Mendelian randomization studies in addition to RCT. The beautiful consistency between RCT and Mendel randomization studies have reassured us that the lower, the better, as well as the earlier, the better appear to be true.
使用他汀类药物、依折麦布和蛋白转化酶枯草素-酮蛋白9型(PCSK9)抑制剂的积极降ldl疗法的临床有效性已经在一级和二级预防环境中得到证实。此外,根据最近的随机对照试验(RCT),低密度脂蛋白越低越好这一观点似乎是正确的,低至~ 30mg /dl。此外,无论是一级预防还是二级预防,积极的低密度脂蛋白降低疗法在日本人群中也显示出相当有效。根据这些事实,欧洲和日本最近的指南建议高危患者将低密度脂蛋白胆固醇(LDL- c)水平降低到< 70 mg/dl。然而,这种“严格”目标的达成率似乎相当低,可能是因为大多数心脏病专家仍然对极低的LDL-C水平感到焦虑。在这篇综述文章中,基于孟德尔随机化研究和随机对照试验的发现,我们提出LDL-C是动脉粥样硬化性心血管疾病(ASCVD)的一个公认的致病因素。随机对照试验和孟德尔随机化研究之间美妙的一致性让我们确信,越低越好,越早越好似乎是正确的。
{"title":"Encouragement of Super-aggressive LDL-lowering Therapies","authors":"H. Tada, K. Sakata, M. Takamura, M. Kawashiri","doi":"10.7793/jcad.25.19-00005","DOIUrl":"https://doi.org/10.7793/jcad.25.19-00005","url":null,"abstract":"Clinical usefulness of aggressive LDL-lowering therapies using statin, ezetimibe, and proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors have been shown in primary as well as in secondary prevention settings. In addition, the idea that the lower, the better story in LDL appears to be true as low as ~30 mg/dl based on recent randomized controlled trials (RCT). Moreover, aggressive LDL-lowering therapies, for either of primary prevention setting, or secondary prevention setting has been shown to be quite effective in Japanese population as well. According to those facts, recent guidelines in Europe, and in Japan suggest to lower LDL cholesterol (LDL-C) level < 70 mg/dl for high-risk patients. However, the attainment rates of such “strict” goals seem to be quite low, probably because most cardiologists still have a feeling of anxiety of extremely low LDL-C level. In this review article, we provide the idea that LDL-C is one of the well-established causal factors for atherosclerotic cardiovascular disease (ASCVD) based on the findings from Mendelian randomization studies in addition to RCT. The beautiful consistency between RCT and Mendel randomization studies have reassured us that the lower, the better, as well as the earlier, the better appear to be true.","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71174296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocardial Bridge 心肌桥
Pub Date : 2019-01-01 DOI: 10.7793/jcad.25.012
Ryotaro Yamada, S. Uemura
A myocardial bridge (MB) is an anatomical variant in which the myocardial muscle partially covers the epicardial coronary arteries -. Although MB can be detected in any coronary artery, most involve the left anterior descending coronary artery (LAD). This variant has historically been regarded as benign, because contraction of the bridged muscles alters blood flow within the underlying LAD during systole, whereas coronary flow in the LAD occurs predominantly during diastole. However, an MB can lead to significant clinical issues, such as arrhythmia, myocardial ischemia conduction disturbances 4, , myocardial infarction 6) and sudden death 7) in a subset of patients. II. Prevalence and diagnostic testing The prevalence of MB varies widely according to the detection methods applied. The reported MB rates among numerous necropsy series (Fig. 1) 8) range from 5% to 86% 9) and an average of ~25% of adults have MB. The reported rates of MB are higher according to pathological series including thin MB or even myocardial strands with minimal hemodynamic consequences, than those determined by coronary angiography, which typically detects systolic compression as a “milking effect” (Fig. 2) . Coronary angiography is the most popular means of diagnosing MB in the clinical setting, with detection rates ranging from 0.5% to 12% at rest and up to 40% upon provocation or after intracoronary nitroglycerin injection 2-4, -. Numerous factors have been presumed to account for the reported mismatch between the rates of “tunneled arteries” that run intramurally through the myocardium compared with angiographic findings. These include MB thickness and length, the reciprocal orientation of the coronary artery and myocardial fibers, loose connective or adipose tissue around the bridged segment, aortic outflow tract obstruction, in which the systolic tension that develops in the MB overcomes the intracoronary artery pressure, the intrinsic tone of the wall of the coronary artery, a proximal coronary fixed obstruction that causes a decrease in distal intracoronary pressure, and the status of myocardial contractility . Intravascular ultrasound (IVUS) can clearly visualize eccentric or concentric systolic compression in the tunneled segment of an artery that persists into diastole 4, 5, 8, -, accompanied by a highly specific echolucent “halfmoon” appearance throughout the cardiac cycle (Fig. 3) 5, 8, . Vessel compression can be detected by IVUS under coronary provocation even in the absence of angiographically significant milking. The prevalence of MB determined by IVUS, which is more sensitive than angiography for detecting minor compression, is 23%. Optical coherence tomography (OCT) can also detect MB with a homogeneous specific “band” appearance outside the adventitia (Fig. 4). Review Article
心肌桥(MB)是一种解剖变异,心肌部分覆盖心外膜冠状动脉。虽然MB可以在任何冠状动脉中检测到,但大多数涉及左冠状动脉前降支(LAD)。这种变异历来被认为是良性的,因为桥状肌肉的收缩改变了LAD收缩期的血流,而LAD的冠状动脉血流主要发生在舒张期。然而,MB可导致严重的临床问题,如心律失常、心肌缺血传导障碍、心肌梗死和一小部分患者猝死。2根据所采用的检测方法,MB的患病率差异很大。在许多尸检系列(图1)中,报道的MB率从5%到86%不等(9),平均约25%的成年人患有MB。根据病理系列(包括薄MB甚至心肌链,血流动力学后果最小),报道的MB率高于冠状动脉造影(通常检测收缩期压缩为“挤乳效应”)(图2)。冠状动脉造影是临床上诊断MB最常用的手段,静息时的检出率为0.5% ~ 12%,刺激时或冠状动脉内注射硝酸甘油后的检出率可达40%。许多因素被认为可以解释与血管造影结果相比较的“隧道动脉”发生率之间的不匹配。这些包括小动脉的厚度和长度,冠状动脉和心肌纤维的相互取向,桥段周围的松散结缔组织或脂肪组织,主动脉流出道阻塞,其中小动脉的收缩张力克服了冠状动脉内压力,冠状动脉壁的固有张力,冠状动脉近端固定阻塞导致冠状动脉远端压力降低,心肌收缩状态。血管内超声(IVUS)可以清楚地看到动脉隧道段的偏心或同心收缩压迫,这种压迫持续到舒张期4,5,8,-,并在整个心脏周期中伴有高度特异性的回声“半月”外观(图3)5,8,。在冠状动脉刺激下,即使没有血管造影上明显的挤乳,IVUS也可以检测到血管受压。IVUS检测MB的患病率为23%,它比血管造影检测轻微压迫更敏感。光学相干断层扫描(OCT)也可以检测到MB在外膜外具有均匀的特定“带”外观(图4)
{"title":"Myocardial Bridge","authors":"Ryotaro Yamada, S. Uemura","doi":"10.7793/jcad.25.012","DOIUrl":"https://doi.org/10.7793/jcad.25.012","url":null,"abstract":"A myocardial bridge (MB) is an anatomical variant in which the myocardial muscle partially covers the epicardial coronary arteries -. Although MB can be detected in any coronary artery, most involve the left anterior descending coronary artery (LAD). This variant has historically been regarded as benign, because contraction of the bridged muscles alters blood flow within the underlying LAD during systole, whereas coronary flow in the LAD occurs predominantly during diastole. However, an MB can lead to significant clinical issues, such as arrhythmia, myocardial ischemia conduction disturbances 4, , myocardial infarction 6) and sudden death 7) in a subset of patients. II. Prevalence and diagnostic testing The prevalence of MB varies widely according to the detection methods applied. The reported MB rates among numerous necropsy series (Fig. 1) 8) range from 5% to 86% 9) and an average of ~25% of adults have MB. The reported rates of MB are higher according to pathological series including thin MB or even myocardial strands with minimal hemodynamic consequences, than those determined by coronary angiography, which typically detects systolic compression as a “milking effect” (Fig. 2) . Coronary angiography is the most popular means of diagnosing MB in the clinical setting, with detection rates ranging from 0.5% to 12% at rest and up to 40% upon provocation or after intracoronary nitroglycerin injection 2-4, -. Numerous factors have been presumed to account for the reported mismatch between the rates of “tunneled arteries” that run intramurally through the myocardium compared with angiographic findings. These include MB thickness and length, the reciprocal orientation of the coronary artery and myocardial fibers, loose connective or adipose tissue around the bridged segment, aortic outflow tract obstruction, in which the systolic tension that develops in the MB overcomes the intracoronary artery pressure, the intrinsic tone of the wall of the coronary artery, a proximal coronary fixed obstruction that causes a decrease in distal intracoronary pressure, and the status of myocardial contractility . Intravascular ultrasound (IVUS) can clearly visualize eccentric or concentric systolic compression in the tunneled segment of an artery that persists into diastole 4, 5, 8, -, accompanied by a highly specific echolucent “halfmoon” appearance throughout the cardiac cycle (Fig. 3) 5, 8, . Vessel compression can be detected by IVUS under coronary provocation even in the absence of angiographically significant milking. The prevalence of MB determined by IVUS, which is more sensitive than angiography for detecting minor compression, is 23%. Optical coherence tomography (OCT) can also detect MB with a homogeneous specific “band” appearance outside the adventitia (Fig. 4). Review Article","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7793/jcad.25.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71174340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single Men Have a Higher Morbidity Risk of Acute Coronary Syndrome at a Younger Age than Married Men 单身男性在年轻时患急性冠状动脉综合征的风险高于已婚男性
Pub Date : 2019-01-01 DOI: 10.7793/jcad.25.19-00010
Yasushi Watanabe, G. Kimura, Shinsuke Taguchi, Yoshiki Uehara, Y. Suematsu
The average age at the time of marriage is increasing in Japan. In addition, the percentages of people who have remained single or who are divorced are increasing . Consequently, the prevalence of single persons is expected to increase. Some studies have indicated that marital status is an important factor associated with mortality and cardiovascular diseases -. Thus, the status of Japan as a country with one of the greatest longevities in the world is at risk. However, few studies have investigated the relationship between the age of acute coronary syndrome (ACS) onset and marital status. We hypothesized that single men might have a greater risk of early-onset ACS and might have more coronary risk factors than married men. This study’s purpose is to reveal that marital status could be one of the coronary risk factors or not.
日本的平均结婚年龄正在上升。此外,保持单身或离婚的人的比例也在增加。因此,单身人士的流行率预计会增加。一些研究表明,婚姻状况是与死亡率和心血管疾病相关的一个重要因素。因此,日本作为世界上最长寿的国家之一的地位岌岌可危。然而,很少有研究探讨急性冠脉综合征(ACS)发病年龄与婚姻状况之间的关系。我们假设单身男性可能比已婚男性有更大的早发性ACS风险,并且可能有更多的冠状动脉危险因素。这项研究的目的是揭示婚姻状况是否可能是冠状动脉危险因素之一。
{"title":"Single Men Have a Higher Morbidity Risk of Acute Coronary Syndrome at a Younger Age than Married Men","authors":"Yasushi Watanabe, G. Kimura, Shinsuke Taguchi, Yoshiki Uehara, Y. Suematsu","doi":"10.7793/jcad.25.19-00010","DOIUrl":"https://doi.org/10.7793/jcad.25.19-00010","url":null,"abstract":"The average age at the time of marriage is increasing in Japan. In addition, the percentages of people who have remained single or who are divorced are increasing . Consequently, the prevalence of single persons is expected to increase. Some studies have indicated that marital status is an important factor associated with mortality and cardiovascular diseases -. Thus, the status of Japan as a country with one of the greatest longevities in the world is at risk. However, few studies have investigated the relationship between the age of acute coronary syndrome (ACS) onset and marital status. We hypothesized that single men might have a greater risk of early-onset ACS and might have more coronary risk factors than married men. This study’s purpose is to reveal that marital status could be one of the coronary risk factors or not.","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71174413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Myocardial Contrast Echocardiography 心肌超声造影术
Pub Date : 2019-01-01 DOI: 10.7793/JCAD.25.006
K. Iwakura
contrast intravenous injection, microbubbles pass Myocardial contrast echocardiography (MCE) is an imaging modality to visualize myocardial perfusion using gas-filled microbubbles. Ultrasound contrast agents containing microbubbles are usually administered intravenously, and small microbubbles flow into left heart through pulmonary circulation. Number of microbubbles flowing into microcirculation would be very small, and image enhancing techniques such as intermittent power Doppler are required to detect weak signal from intramyocardial microbubbles. Fragile microbubbles are easily destroyed by incident ultrasound. When contrast agent is administered by continuous intravenous infusion, microbubbles are replenished into capillaries after microbubble destruction by ultrasound pulse. By analyzing the temporal recovery of myocardial contrast enhancement after microbubble destruction (a replenishment curve), myocardial blood flow could be determined. Such quantitative analysis can be performed using intermittent imaging technique or real-time MCE at low mechanical index (MI) ultrasound. MCE detects microvascular dysfunction (no-reflow phenomenon) in patients with acute myocardial infarction, which determines functional and clinical outcomes. MCE using stress testing could detect myocardial ischemia in patients with coronary artery disease (CAD). Theoretically, MCE could detect endocardial ischemia and diagnose CAD better than single-photon emission computed tomography (SPECT) because of higher spatial resolution. However, large-scale clinical studies failed to demonstrate superiority of MCE to SPECT for detecting CAD. No contrast agent is still approved for MCE, and further improvement of microbubbles and imaging techniques is required.
心肌对比超声心动图(MCE)是一种利用充满气体的微泡来观察心肌灌注的成像方式。含有微泡的超声造影剂通常通过静脉注射,小的微泡通过肺循环流入左心。流入微循环的微泡数量将非常少,需要间歇性功率多普勒等图像增强技术来检测心内微泡的微弱信号。脆弱的微气泡很容易被入射超声破坏。造影剂连续静脉输注时,超声脉冲破坏微泡后,微泡被补充到毛细血管中。通过分析微泡破坏后心肌造影剂增强的时间恢复(补血曲线),确定心肌血流量。这种定量分析可以使用间歇成像技术或低机械指数(MI)超声下的实时MCE进行。MCE检测急性心肌梗死患者微血管功能障碍(无回流现象),决定功能和临床结局。MCE应用应激试验可以检测冠心病(CAD)患者心肌缺血情况。理论上,MCE比单光子发射计算机断层扫描(SPECT)具有更高的空间分辨率,可以更好地检测心内膜缺血和诊断CAD。然而,大规模的临床研究未能证明MCE在检测CAD方面优于SPECT。目前还没有造影剂被批准用于MCE,需要进一步改进微泡和成像技术。
{"title":"Myocardial Contrast Echocardiography","authors":"K. Iwakura","doi":"10.7793/JCAD.25.006","DOIUrl":"https://doi.org/10.7793/JCAD.25.006","url":null,"abstract":"contrast intravenous injection, microbubbles pass Myocardial contrast echocardiography (MCE) is an imaging modality to visualize myocardial perfusion using gas-filled microbubbles. Ultrasound contrast agents containing microbubbles are usually administered intravenously, and small microbubbles flow into left heart through pulmonary circulation. Number of microbubbles flowing into microcirculation would be very small, and image enhancing techniques such as intermittent power Doppler are required to detect weak signal from intramyocardial microbubbles. Fragile microbubbles are easily destroyed by incident ultrasound. When contrast agent is administered by continuous intravenous infusion, microbubbles are replenished into capillaries after microbubble destruction by ultrasound pulse. By analyzing the temporal recovery of myocardial contrast enhancement after microbubble destruction (a replenishment curve), myocardial blood flow could be determined. Such quantitative analysis can be performed using intermittent imaging technique or real-time MCE at low mechanical index (MI) ultrasound. MCE detects microvascular dysfunction (no-reflow phenomenon) in patients with acute myocardial infarction, which determines functional and clinical outcomes. MCE using stress testing could detect myocardial ischemia in patients with coronary artery disease (CAD). Theoretically, MCE could detect endocardial ischemia and diagnose CAD better than single-photon emission computed tomography (SPECT) because of higher spatial resolution. However, large-scale clinical studies failed to demonstrate superiority of MCE to SPECT for detecting CAD. No contrast agent is still approved for MCE, and further improvement of microbubbles and imaging techniques is required.","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7793/JCAD.25.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71173530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ischemic Mitral Regurgitation 缺血性二尖瓣返流
Pub Date : 2019-01-01 DOI: 10.7793/JCAD.25.003
H. Takemura
Ischemic mitral regurgitation (MR) is defined as functional MR caused by myocardial ischemia including myocardial infarction and ischemic cardiomyoplasty that results in disturbed left ventricular (LV) geometry. It does not usually coexist with rheumatic heart valve disease, degenerative disease, or congenital defect of the mitral valve (MV) 1) and is associated with excess mortality independently of baseline characteristics and the severity of ventricular dysfunction . The mechanism of regurgitation is independently multifactorial, including LV dilation, LV sphericity, apical and posterior displacement of the papillary muscle, and LV function. Apical and posterior displacement, referred to as tethering, positively correlates with maximal regurgitation area 1, . II. Moderate mitral regurgitation at coronary artery bypass surgery
缺血性二尖瓣反流(MR)被定义为心肌缺血引起的功能性MR,包括心肌梗死和缺血性心肌成形术,导致左心室(LV)几何形状紊乱。它通常不会与风湿性心脏瓣膜疾病、退行性疾病或先天性二尖瓣缺陷(MV)共存,并且与独立于基线特征和心室功能障碍严重程度的高死亡率相关。反流的机制是独立的多因素机制,包括左室扩张、左室球形、乳头肌顶端和后部移位以及左室功能。根尖和后部移位,称为栓系,与最大反流面积呈正相关。2冠状动脉搭桥术中中度二尖瓣返流
{"title":"Ischemic Mitral Regurgitation","authors":"H. Takemura","doi":"10.7793/JCAD.25.003","DOIUrl":"https://doi.org/10.7793/JCAD.25.003","url":null,"abstract":"Ischemic mitral regurgitation (MR) is defined as functional MR caused by myocardial ischemia including myocardial infarction and ischemic cardiomyoplasty that results in disturbed left ventricular (LV) geometry. It does not usually coexist with rheumatic heart valve disease, degenerative disease, or congenital defect of the mitral valve (MV) 1) and is associated with excess mortality independently of baseline characteristics and the severity of ventricular dysfunction . The mechanism of regurgitation is independently multifactorial, including LV dilation, LV sphericity, apical and posterior displacement of the papillary muscle, and LV function. Apical and posterior displacement, referred to as tethering, positively correlates with maximal regurgitation area 1, . II. Moderate mitral regurgitation at coronary artery bypass surgery","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71173758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Update Review on Postinfarction Ventricular Septal Rupture 梗死后室间隔破裂的最新研究进展
Pub Date : 2019-01-01 DOI: 10.7793/JCAD.25.004
T. Asai
Before the introduction of reperfusion therapies, VSR occurred in 1 to 3 percent of AMI cases 1 -. In the era of reperfusion therapy, Crenshaw et al. reported the VSR incidence in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial (GUSTO-I) at 0.2 percent, which indicated a reduction of the incidence of VSR since the introduction of reperfusion therapies . In spite of this reported reduction the real-world incidence may not have continued to improve as much as one might hope. Moreyra et al. found from the MIDAS database that the rate of VSR had not changed from 1990 to 2007, and that mortality had remained high and relatively constant . Annual reports from The Japanese Association for Thoracic Surgery, including data from almost all the centers nationwide demonstrated fairly consistent numbers of VSR repairs, ranging from 275 to 296 cases annually from 2010 to 2017 -. VSR is more probable after anterior myocardial infarction than after inferior infarction 6, . Risk factors for VSR in the pre-reperfusion era included hypertension 15, , advanced age (60 to 69 years) , female sex 15, , and no history of angina or myocardial infarction 1, 2, -. Angina or myocardial infarction may stimulate the growth of coronary collaterals, which may reduce the development of rupture . In the reperfusion era, advanced age, female sex, and the absence of smoking are often associated with an increased risk of developing VSR , but the absence of previous angina has not been associated with an increased risk .
在引入再灌注治疗之前,1 - 3%的AMI病例发生VSR。在再灌注治疗时代,Crenshaw等人在Global Utilization of Streptokinase and TPA for Occluded冠脉试验(GUSTO-I)中报道了VSR的发生率为0.2%,这表明自引入再灌注治疗以来VSR的发生率有所降低。尽管报告的发病率有所下降,但现实世界的发病率可能没有像人们希望的那样继续改善。Moreyra等人从MIDAS数据库中发现,从1990年到2007年,VSR率没有变化,死亡率保持较高且相对稳定。日本胸外科协会的年度报告,包括来自全国几乎所有中心的数据,显示了相当一致的VSR修复数量,从2010年到2017年,每年的数量从275例到296例不等。前路心肌梗死比下路心肌梗死更容易发生VSR 6,。再灌注前发生VSR的危险因素包括高血压15、高龄(60 ~ 69岁)、女性15、无心绞痛或心肌梗死史1,2,-。心绞痛或心肌梗塞可刺激冠状动脉侧枝的生长,从而减少破裂的发生。在再灌注时代,高龄、女性和不吸烟通常与VSR发生风险增加相关,但既往无心绞痛与VSR发生风险增加无关。
{"title":"An Update Review on Postinfarction Ventricular Septal Rupture","authors":"T. Asai","doi":"10.7793/JCAD.25.004","DOIUrl":"https://doi.org/10.7793/JCAD.25.004","url":null,"abstract":"Before the introduction of reperfusion therapies, VSR occurred in 1 to 3 percent of AMI cases 1 -. In the era of reperfusion therapy, Crenshaw et al. reported the VSR incidence in the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries trial (GUSTO-I) at 0.2 percent, which indicated a reduction of the incidence of VSR since the introduction of reperfusion therapies . In spite of this reported reduction the real-world incidence may not have continued to improve as much as one might hope. Moreyra et al. found from the MIDAS database that the rate of VSR had not changed from 1990 to 2007, and that mortality had remained high and relatively constant . Annual reports from The Japanese Association for Thoracic Surgery, including data from almost all the centers nationwide demonstrated fairly consistent numbers of VSR repairs, ranging from 275 to 296 cases annually from 2010 to 2017 -. VSR is more probable after anterior myocardial infarction than after inferior infarction 6, . Risk factors for VSR in the pre-reperfusion era included hypertension 15, , advanced age (60 to 69 years) , female sex 15, , and no history of angina or myocardial infarction 1, 2, -. Angina or myocardial infarction may stimulate the growth of coronary collaterals, which may reduce the development of rupture . In the reperfusion era, advanced age, female sex, and the absence of smoking are often associated with an increased risk of developing VSR , but the absence of previous angina has not been associated with an increased risk .","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7793/JCAD.25.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71173962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The Ultimate Goals of Surgical Ventricular Reconstruction 外科心室重建的最终目的
Pub Date : 2019-01-01 DOI: 10.7793/JCAD.25.007
S. Yamazaki, S. Numata, H. Yaku
{"title":"The Ultimate Goals of Surgical Ventricular Reconstruction","authors":"S. Yamazaki, S. Numata, H. Yaku","doi":"10.7793/JCAD.25.007","DOIUrl":"https://doi.org/10.7793/JCAD.25.007","url":null,"abstract":"","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71174114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Therapy for Anomalous Aortic Origin of a Coronary Artery 冠状动脉异常起源的外科治疗
Pub Date : 2019-01-01 DOI: 10.7793/jcad.25.011
K. Furukawa, A. Shiose
ob-struction and cause ischemic cardiac events. Anomalous aortic origin of a coronary artery is a congenital anomaly that carries a risk of a life-threatening cardiovascular event, such as sudden cardiac death or myocardial infarction. Some therapeutic guidelines have been proposed, but specific indications and treatment procedures remain controversial. In general, all patients with anomalous aortic origin of the left coronary artery are indicated for surgical repair, whereas surgical indications for anomalous aortic origin of the right coronary artery have not been established. Various surgical therapies (e.g., coronary artery bypass graft, unroofing, reimplantation, and pulmonary artery translocation) have been reported. The unroofing procedure is presumably a reasonable and safe approach for revascularization in patients with anomalous aortic origin of a coronary artery with a long intramural course, despite the risk of aortic insufficiency or recurrent sudden cardiac arrest. Among surgical procedures, reimplantation is conceivably the most physiologically appropriate and durable procedure. However, the procedure is technically demanding procedure because of the requirement for extensive dissection and vessel mobilization. Currently, optical surgical intervention is proposed based on coronary anatomy. With increasing numbers of treated patients and improved diagnostic tools, based on both anatomy and function, this anomaly may be definitely resolved in the near future.
阻塞并引起缺血性心脏事件。冠状动脉主动脉异常是一种先天性异常,有发生危及生命的心血管事件的风险,如心源性猝死或心肌梗死。已经提出了一些治疗指南,但具体的适应症和治疗方法仍然存在争议。一般来说,所有左冠状动脉主动脉起源地异常的患者都需要手术修复,而右冠状动脉主动脉起源地异常的手术指征尚未确定。各种外科治疗(如冠状动脉旁路移植术、去顶术、再植和肺动脉移位)已被报道。尽管存在主动脉功能不全或复发性心脏骤停的风险,但对于长血管内路程的冠状动脉异常起源地患者,开颅手术可能是一种合理且安全的血运重建方法。在外科手术中,再植是生理上最合适和最持久的手术。然而,由于需要广泛的解剖和血管活动,该手术在技术上要求很高。目前,建议基于冠状动脉解剖进行光学手术干预。随着治疗患者数量的增加和基于解剖和功能的诊断工具的改进,这种异常可能在不久的将来肯定会得到解决。
{"title":"Surgical Therapy for Anomalous Aortic Origin of a Coronary Artery","authors":"K. Furukawa, A. Shiose","doi":"10.7793/jcad.25.011","DOIUrl":"https://doi.org/10.7793/jcad.25.011","url":null,"abstract":"ob-struction and cause ischemic cardiac events. Anomalous aortic origin of a coronary artery is a congenital anomaly that carries a risk of a life-threatening cardiovascular event, such as sudden cardiac death or myocardial infarction. Some therapeutic guidelines have been proposed, but specific indications and treatment procedures remain controversial. In general, all patients with anomalous aortic origin of the left coronary artery are indicated for surgical repair, whereas surgical indications for anomalous aortic origin of the right coronary artery have not been established. Various surgical therapies (e.g., coronary artery bypass graft, unroofing, reimplantation, and pulmonary artery translocation) have been reported. The unroofing procedure is presumably a reasonable and safe approach for revascularization in patients with anomalous aortic origin of a coronary artery with a long intramural course, despite the risk of aortic insufficiency or recurrent sudden cardiac arrest. Among surgical procedures, reimplantation is conceivably the most physiologically appropriate and durable procedure. However, the procedure is technically demanding procedure because of the requirement for extensive dissection and vessel mobilization. Currently, optical surgical intervention is proposed based on coronary anatomy. With increasing numbers of treated patients and improved diagnostic tools, based on both anatomy and function, this anomaly may be definitely resolved in the near future.","PeriodicalId":73692,"journal":{"name":"Journal of coronary artery disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71174328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Journal of coronary artery disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1